fluoxetine has been researched along with Post-Natal Depression in 31 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " PPD rat models were prepared by withdrawing hormone‑simulated pregnancy (HSP), and subjects were treated with paeoniflorin and fluoxetine or plasmids." | 4.12 | Paeoniflorin exhibits antidepressant activity in rats with postpartum depression via the TSPO and BDNF‑mTOR pathways. ( Chen, J; Hu, L; Peng, H; Yang, K; Zeng, X; Zhu, W, 2022) |
| " The women were on stable daily doses of fluoxetine (10-60 mg/day) and all but two took the medication during the last trimester of pregnancy." | 3.71 | Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. ( Altshuler, LL; Fukuchi, A; Hendrick, V; Hostetter, A; Hwang, S; Leight, K; Mintz, J; Stowe, ZN; Suri, R, 2001) |
| "Postnatal depression is a common disorder that can have adverse short- and long-term effects on maternal morbidity, the new infant and the family as a whole." | 2.50 | Antidepressant treatment for postnatal depression. ( Howard, LM; Karia, AM; McGeown, HR; Molyneaux, E; Trevillion, K, 2014) |
| "Women with postnatal depression can be effectively treated with fluoxetine, which is as effective as a course of cognitive-behavioural counselling in the short-term." | 2.41 | Antidepressant drug treatment for postnatal depression. ( Crawley, H; Hoffbrand, S; Howard, L, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (22.58) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 5 (16.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Zhu, W | 1 |
| Zeng, X | 1 |
| Yang, K | 1 |
| Peng, H | 1 |
| Hu, L | 1 |
| Guo, YJ | 1 |
| Shan, YM | 1 |
| Wang, ZJ | 1 |
| Shen, ZF | 1 |
| Qiu, W | 2 |
| Duarte-Guterman, P | 1 |
| Eid, RS | 1 |
| Go, KA | 2 |
| Lamers, Y | 2 |
| Galea, LAM | 4 |
| Bashiri, H | 1 |
| Houwing, DJ | 1 |
| Homberg, JR | 1 |
| Salari, AA | 1 |
| Gobinath, AR | 2 |
| Wong, S | 1 |
| Chow, C | 2 |
| Lieblich, SE | 1 |
| Barr, AM | 1 |
| Hu, Z | 1 |
| Du, X | 1 |
| Yang, Y | 1 |
| Botchway, BOA | 1 |
| Fang, M | 1 |
| Arbabi, L | 1 |
| Baharuldin, MT | 1 |
| Moklas, MA | 1 |
| Fakurazi, S | 1 |
| Muhammad, SI | 1 |
| Molyneaux, E | 1 |
| Howard, LM | 1 |
| McGeown, HR | 1 |
| Karia, AM | 1 |
| Trevillion, K | 1 |
| Workman, JL | 1 |
| Kitay, NF | 1 |
| Brummelte, S | 1 |
| Kashani, L | 1 |
| Eslatmanesh, S | 1 |
| Saedi, N | 1 |
| Niroomand, N | 1 |
| Ebrahimi, M | 1 |
| Hosseinian, M | 1 |
| Foroughifar, T | 1 |
| Salimi, S | 1 |
| Akhondzadeh, S | 1 |
| Lanza di Scalea, T | 1 |
| Wisner, KL | 2 |
| Suri, R | 2 |
| Stowe, ZN | 2 |
| Hendrick, V | 2 |
| Hostetter, A | 2 |
| Widawski, M | 1 |
| Altshuler, LL | 2 |
| Sohn, E | 1 |
| Howard, L | 4 |
| Sanders, J | 1 |
| Whitty, P | 1 |
| Murray, D | 1 |
| Devitt, P | 1 |
| Rojas, G | 1 |
| Fritsch, R | 1 |
| Solis, J | 1 |
| Jadresic, E | 1 |
| Castillo, C | 1 |
| González, M | 1 |
| Guajardo, V | 1 |
| Lewis, G | 1 |
| Peters, TJ | 1 |
| Araya, R | 1 |
| Parry, BL | 2 |
| Perel, JM | 1 |
| Findling, RL | 1 |
| Symonds, A | 1 |
| Appleby, L | 1 |
| Warner, R | 1 |
| Whitton, A | 1 |
| Faragher, B | 1 |
| Dalton, K | 1 |
| Herxheimer, A | 1 |
| Pasco, J | 1 |
| Gupta, S | 1 |
| Masand, PS | 1 |
| Rangwani, S | 1 |
| Gard, PR | 1 |
| Mandy, A | 1 |
| Sutcliffe, MA | 1 |
| Hoffbrand, S | 1 |
| Crawley, H | 1 |
| Nordeng, H | 1 |
| Bergsholm, YK | 1 |
| Bøhler, E | 1 |
| Spigset, O | 1 |
| Newton, RP | 1 |
| Mintz, J | 1 |
| Hwang, S | 1 |
| Leight, K | 1 |
| Fukuchi, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Clinical Trial for the Treatment of Postnatal Depression[NCT00518830] | 230 participants (Actual) | Interventional | 2004-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for fluoxetine and Post-Natal Depression
| Article | Year |
|---|---|
Antidepressant treatment for postnatal depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression, Postpartum; F | 2014 |
Antidepressant medication use during breastfeeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; Depression, Postpartum; Female | 2009 |
Postnatal depression.
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Counseling; Depression, Post | 2004 |
Postnatal depression.
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Counseling; Depression, Post | 2005 |
Postnatal depression.
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Counseling; Depression, Post | 2006 |
Perimenopausal depression.
Topics: Administration, Cutaneous; Combined Modality Therapy; Comorbidity; Depression, Postpartum; Depressiv | 2008 |
Antidepressant treatment during breast-feeding.
Topics: Age Factors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Breast Feeding; Depression, Po | 1996 |
Selective serotonin reuptake inhibitors in pregnancy and lactation.
Topics: Animals; Breast Feeding; Depression; Depression, Postpartum; Female; Fluoxetine; Humans; Pregnancy; | 1998 |
Antidepressant drug treatment for postnatal depression.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression, Postpartum; Female; | 2001 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, P | 2001 |
4 trials available for fluoxetine and Post-Natal Depression
| Article | Year |
|---|---|
Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial.
Topics: Adolescent; Adult; Crocus; Depression, Postpartum; Double-Blind Method; Female; Fluoxetine; Humans; | 2017 |
Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial.
Topics: Adult; Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Chile; Depression, Post | 2007 |
A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality The | 1997 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, P | 2001 |
18 other studies available for fluoxetine and Post-Natal Depression
| Article | Year |
|---|---|
Paeoniflorin exhibits antidepressant activity in rats with postpartum depression via the TSPO and BDNF‑mTOR pathways.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Carrier Proteins; Corticosterone; | 2022 |
Efficacy of transcranial magnetic stimulation and fluoxetine in the treatment of postpartum depression: A protocol for systematic review and meta-analysis.
Topics: Adult; Combined Modality Therapy; Depression, Postpartum; Female; Fluoxetine; Humans; Meta-Analysis | 2020 |
Postpartum fluoxetine increased maternal inflammatory signalling and decreased tryptophan metabolism: Clues for efficacy.
Topics: Animals; Depression, Postpartum; Disease Models, Animal; Female; Fluoxetine; Frontal Lobe; Hippocamp | 2020 |
The combination of fluoxetine and environmental enrichment reduces postpartum stress-related behaviors through the oxytocinergic system and HPA axis in mice.
Topics: Animals; Anxiety; Anxiety Disorders; Brain; Depression, Postpartum; Disease Models, Animal; Female; | 2021 |
Postpartum corticosterone and fluoxetine shift the tryptophan-kynurenine pathway in dams.
Topics: Animals; Corticosterone; Depression, Postpartum; Depressive Disorder, Major; Female; Fluoxetine; Hum | 2021 |
Maternal exercise increases but concurrent maternal fluoxetine prevents the increase in hippocampal neurogenesis of adult offspring.
Topics: Animals; Anxiety; Corticosterone; Depression, Postpartum; Disease Models, Animal; Doublecortin Domai | 2018 |
Progesterone and fluoxetine treatments of postpartum depressive-like behavior in rat model.
Topics: Animals; Behavior, Animal; Depression, Postpartum; Disease Models, Animal; Female; Fluoxetine; Hippo | 2019 |
Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Cytokines; Depression, Postpartum; | 2014 |
Parity modifies the effects of fluoxetine and corticosterone on behavior, stress reactivity, and hippocampal neurogenesis.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Corticosterone; Dentate Gyrus; | 2016 |
Estimates of nursing infant daily dose of fluoxetine through breast milk.
Topics: Adult; Antidepressive Agents, Second-Generation; Breast Feeding; Depression, Postpartum; Female; Flu | 2002 |
Nursing kids on prozac.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Depression, Postpartum; Female; Fluoxetine | 2003 |
Delusions or obsessions: the same only different? A case report.
Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Delusions; Depression, Postpartum; D | 2006 |
The mind and the butt.
Topics: Adult; Buttocks; Combined Modality Therapy; Depression, Postpartum; Female; Fluoxetine; Humans; Obse | 1996 |
Treatment of postnatal depression. Additional information would enhance value of study.
Topics: Antidepressive Agents, Second-Generation; Depression, Postpartum; Female; Fluoxetine; Humans; Patien | 1997 |
Emergency medicine. Is this a drug reaction?
Topics: Adult; Analgesics, Opioid; Biliary Tract Diseases; Colic; Depression, Postpartum; Diagnosis, Differe | 1998 |
Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidepressive Agents; Ant | 1999 |
[The transfer of selective serotonin reuptake inhibitors to human milk].
Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvo | 2001 |
Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk.
Topics: Breast Feeding; Depression, Postpartum; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans | 2001 |